Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China
← catalyst calendarSponsored by Daiichi Sankyo (industry) · 4568.T — their whole pipeline →. With Daiichi Sankyo Co., Ltd..
Phase
—
Status
Completed
Study type
Observational
Enrollment
1,271actual
Sites
10
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-08-16 | actual | When the study began enrolling |
| Primary completion | 2025-07-18 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-07-18 | actual | The whole study's end, after follow-up |
| First posted | 2024-08-09 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-07-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Diabetic Peripheral Neuropathic Pain
- Chemotherapy-induced Peripheral Neuropathy
- Neuropathic Pain
Intervention
- Other: No Drug
Primary outcomes
what the primary-completion date above is the date OFProportion of participants receiving different treatment regimens (targeted medications or combinations) and related medication categories in participants with DPNP or CIPN
measured From index date up to 31st December 2022
Proportion of participants who discontinue/switch/add-on treatment and related medication categories in participants with DPNP or CIPN
measured From index date up to 31st December 2022
Proportion of participants who restarted treatment after discontinuation in participants with DPNP or CIPN
measured From index date up to 31st December 2022
Duration of the current treatment in participants with DPNP or CIPN
measured From index date up to 31st December 2022
Time to treatment add-on in participants with DPNP or CIPN
measured From index date up to 31st December 2022
Publications
- PMID 40788612 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · 4568.T's whole pipeline · Catalyst calendar · Every registered study · What changed